Honokiol Decreases Lung Cancer Metastasis through Inhibition of the STAT3 Signaling Pathway

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Cancer Prevention Research

• Publication date

  2016-11-14

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/1940-6207.CAPR-16-0129PMID 27849557PMCID PMC6005650
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Lung Cancer Brain Metastases

  2015influential reference
• Honokiol blocks and reverses cardiac hypertrophy in mice by activating mitochondrial SIRT3

  2015cited by this paper
• Honokiol inhibits the growth of head and neck squamous cell carcinoma by targeting epidermal growth factor receptor

  2015cited by this paper
• STAT3 Inhibition Enhances the Therapeutic Efficacy of Immunogenic Chemotherapy by Stimulating Type 1 Interferon Production by Cancer Cells.

  2015cited by this paper
• EGFR–STAT3 signaling promotes formation of malignant peripheral nerve sheath tumors

  2014cited by this paper
• ALK inhibitors in non-small cell lung cancer: crizotinib and beyond.

  2014cited by this paper
• HTSeq—a Python framework to work with high-throughput sequencing data

  2014cited by this paper
• Th17-type cytokines, IL-6 and TNF-α synergistically activate STAT3 and NF-kB to promote colorectal cancer cell growth

  2014cited by this paper
• Honokiol Inhibits Lung Tumorigenesis through Inhibition of Mitochondrial Function

  2014influential reference
• Honokiol Inhibits Non-Small Cell Lung Cancer Cell Migration by Targeting PGE2-Mediated Activation of β-Catenin Signaling

  2013cited by this paper
• RNA-Seq Differentiates Tumour and Host mRNA Expression Changes Induced by Treatment of Human Tumour Xenografts with the VEGFR Tyrosine Kinase Inhibitor Cediranib

  2013cited by this paper
• Inducing apoptosis of cancer cells using small-molecule plant compounds that bind to GRP78

  2013cited by this paper
• Next-Generation Sequence Analysis of Cancer Xenograft Models

  2013cited by this paper
• Mitochondrial Localized Stat3 Promotes Breast Cancer Growth via Phosphorylation of Serine 727*

  2013cited by this paper
• Honokiol traverses the blood-brain barrier and induces apoptosis of neuroblastoma cells via an intrinsic bax-mitochondrion-cytochrome c-caspase protease pathway.

  2012influential reference
• Honokiol activates AMP-activated protein kinase in breast cancer cells via an LKB1-dependent pathway and inhibits breast carcinogenesis

  2012cited by this paper
• Honokiol: a novel natural agent for cancer prevention and therapy.

  2012cited by this paper
• Honokiol Crosses BBB and BCSFB, and Inhibits Brain Tumor Growth in Rat 9L Intracerebral Gliosarcoma Model and Human U251 Xenograft Glioma Model

  2011cited by this paper
• STAT3 is necessary for proliferation and survival in colon cancer-initiating cells.

  2011cited by this paper
• The FGFR4-G388R Polymorphism Promotes Mitochondrial STAT3 Serine Phosphorylation to Facilitate Pituitary Growth Hormone Cell Tumorigenesis

  2011cited by this paper
• Honokiol Arrests Cell Cycle, Induces Apoptosis, and Potentiates the Cytotoxic Effect of Gemcitabine in Human Pancreatic Cancer Cells

  2011cited by this paper
• Honokiol induces cell apoptosis in human chondrosarcoma cells through mitochondrial dysfunction and endoplasmic reticulum stress.

  2010cited by this paper
• Cancer Statistics, 2010

  2010cited by this paper
• Searching for SNPs with cloud computing

  2009cited by this paper
• Down-regulation of c-Src/EGFR-mediated signaling activation is involved in the honokiol-induced cell cycle arrest and apoptosis in MDA-MB-231 human breast cancer cells.

  2009cited by this paper
• Ultrafast and memory-efficient alignment of short DNA sequences to the human genome

  2009cited by this paper
• Honokiol-mediated Inhibition of PI3K/mTOR Pathway: A Potential Strategy to Overcome Immunoresistance in Glioma, Breast, and Prostate Carcinoma Without Impacting T Cell Function

  2009cited by this paper
• TopHat: discovering splice junctions with RNA-Seq

  2009cited by this paper
• edgeR: a Bioconductor package for differential expression analysis of digital gene expression data

  2009cited by this paper
• WNT/TCF signaling through LEF1 and HOXB9 mediates lung adenocarcinoma metastasis.

  2009cited by this paper
• Involvement of p38 mitogen‐activated protein kinase pathway in honokiol‐induced apoptosis in a human hepatoma cell line (hepG2)

  2008influential reference
• Honokiol Suppresses Survival Signals Mediated by Ras-Dependent Phospholipase D Activity in Human Cancer Cells

  2008influential reference
• Honokiol causes G0-G1 phase cell cycle arrest in human prostate cancer cells in association with suppression of retinoblastoma protein level/phosphorylation and inhibition of E2F1 transcriptional activity

  2007cited by this paper
• Activation of the PTEN/mTOR/STAT3 pathway in breast cancer stem-like cells is required for viability and maintenance

  2007cited by this paper
• Inhibition of integrin-linked kinase by a selective small molecule inhibitor, QLT0254, inhibits the PI3K/PKB/mTOR, Stat3, and FKHR pathways and tumor growth, and enhances gemcitabine-induced apoptosis in human orthotopic primary pancreatic cancer xenografts.

  2005cited by this paper
• Honokiol inhibits TNF-α-stimulated NF-κB activation and NF-κB-regulated gene expression through suppression of IKK activation

  2005cited by this paper
• Establishment of a human non‐small cell lung cancer cell line resistant to gefitinib

  2005cited by this paper
• Honokiol inhibits TNF-alpha-stimulated NF-kappaB activation and NF-kappaB-regulated gene expression through suppression of IKK activation.

  2005influential reference
• Honokiol: a potent chemotherapy candidate for human colorectal carcinoma.

  2004cited by this paper
• NCI‐navy medical oncology branch cell line data base

  1996cited by this paper
• Pharmacokinetics of honokiol after intravenous administration in rats assessed using high-performance liquid chromatography.

  1994cited by this paper
• Cancer statistics

  1989cited by this paper

• Traditional Chinese medicine in lung cancer treatment

  2025cites this paper
• Determine the Antimetastasis Effect of Artesunate in Lung Cancer‐Driven Brain Metastasis Model

  2025cites this paper
• The Role of Plant-Derived Natural Products as a Regulator of the Tyrosine Kinase Pathway in the Management of Lung Cancer

  2025cites this paper
• Updated progression of honokiol in lung cancer treatment.

  2025cites this paper
• A comprehensive review of anti-cancer mechanisms of polyphenol honokiol and nano carrier-based approaches to enhance its therapeutic potential

  2025cites this paper
• Antibacterial, Photoprotective, Anti-Inflammatory, and Selected Anticancer Properties of Honokiol Extracted from Plants of the Genus Magnolia and Used in the Treatment of Dermatological Problems—A Review

  2025cites this paper
• Recent advances of honokiol：pharmacological activities, manmade derivatives and structure-activity relationship.

  2024cites this paper
• Honokiol-loaded PLGA-PEG nanoparticles with solubility in water for infusion treatment of solid cancer

  2024cites this paper
• Overcoming drug resistance of cancer cells by targeting the FGF1/FGFR1 axis with honokiol or FGF ligand trap

  2024cites this paper
• Andrographolide targets EGFR to impede epithelial-mesenchymal transition in human breast cancer cells.

  2024cites this paper
• Honokiol induces apoptosis and autophagy in dexamethasone-resistant T-acute lymphoblastic leukemia CEM-C1 cells

  2024cites this paper
• Natural STAT3 inhibitors for cancer treatment: A Comprehensive Literature Review.

  2023cites this paper
• Lung cancer treatment in traditional chinese medicine: History, current status, and development

  2023cites this paper
• Tumor-targeted delivery of honokiol via polysialic acid modified zein nanoparticles prevents breast cancer progression and metastasis.

  2022cites this paper
• Traditional Chinese Medicine has great potential as candidate drugs for lung cancer: A review.

  2022cites this paper
• Pharmacological features, health benefits and clinical implications of honokiol

  2022influential citation
• Loss of Nuclear Envelope Integrity and Increased Oxidant Production Cause DNA Damage in Adult Hearts Deficient in PKP2: A Molecular Substrate of ARVC

  2022cites this paper
• Honokiol: A review of its pharmacological potential and therapeutic insights.

  2021influential citation
• Liposomal honokiol inhibits glioblastoma growth through regulating macrophage polarization

  2021cites this paper
• Glioblastoma cell-induced immunosuppression causing chemoresistance

  2021cites this paper
• Synergistic killing effect of paclitaxel and honokiol in non-small cell lung cancer cells through paraptosis induction

  2020cites this paper
• Overcoming acquired resistance of EGFR‐mutant NSCLC cells to the third generation EGFR inhibitor, osimertinib, with the natural product honokiol

  2020cites this paper
• Hyaluronic acid-modified liposomal honokiol nanocarrier: Enhance anti-metastasis and antitumor efficacy against breast cancer.

  2020cites this paper
• Effectiveness in the Block by Honokiol, a Dimerized Allylphenol from Magnolia Officinalis, of Hyperpolarization-Activated Cation Current and Delayed-Rectifier K+ Current

  2020cites this paper
• Honokiol-Chlorambucil Co-Prodrugs Selectively Enhance the Killing Effect through STAT3 Binding on Lymphocytic Leukemia Cells In Vitro and In Vivo

  2020cites this paper
• Anti-proliferative effect of honokiol on SW620 cells through upregulating BMP7 expression via the TGF-β1/p53 signaling pathway

  2020cites this paper
• Anti ‐ proliferative effect of honokiol on SW 620 cells through upregulating BMP 7 expression via the TGF ‐ β 1 / p 53 signaling pathway

  2020cites this paper
• Exosomal Formulation Escalates Cellular Uptake of Honokiol Leading to the Enhancement of Its Antitumor Efficacy

  2020cites this paper
• The pleiotropic role of transcription factor STAT3 in oncogenesis and its targeting through natural products for cancer prevention and therapy

  2020cites this paper
• Synergistic killing effect of paclitaxel and honokiol in non-small cell lung cancer cells through paraptosis induction

  2020cites this paper
• Honokiol: A Review of Its Anticancer Potential and Mechanisms

  2019influential citation
• Cancer Biomarkers for Integrative Oncology

  2019cites this paper
• Honokiol induces endoplasmic reticulum stress‐mediated apoptosis in human lung cancer cells

  2019cites this paper
• Honokiol for cancer therapeutics: A traditional medicine that can modulate multiple oncogenic targets.

  2019cites this paper
• Honokiol antagonizes doxorubicin-induced cardiomyocyte senescence by inhibiting TXNIP-mediated NLRP3 inflammasome activation

  2019cites this paper
• Liposome Delivery of Natural STAT3 Inhibitors for the Treatment of Cancer.

  2019cites this paper
• Development of a Novel STAT3 Inhibitor for the Treatment and Chemoprevention of Lung Cancer

  2019cites this paper
• Mitochondria-Targeted Honokiol Confers a Striking Inhibitory Effect on Lung Cancer via Inhibiting Complex I Activity

  2018cites this paper
• Proteomic analysis of honokiol‐induced cytotoxicity in thyroid cancer cells

  2018cites this paper
• YAP and TAZ in Lung Cancer: Oncogenic Role and Clinical Targeting

  2018cites this paper
• Targeting oncogenic transcription factors by polyphenols: A novel approach for cancer therapy

  2018cites this paper
• 15-Lipoxygenase-2/15(S)-hydroxyeicosatetraenoic acid regulates cell proliferation and metastasis via the STAT3 pathway in lung adenocarcinoma.

  2018cites this paper
• Honokiol Induces Apoptosis, G1 Arrest, and Autophagy in KRAS Mutant Lung Cancer Cells

  2017cites this paper
• Honokiol-Inspired Analogs as Inhibitors of Oral Bacteria.

  2017cites this paper
• Development and validation of assays used to evaluate STAT3 inhibitors

  2017cites this paper
• Honokiol protects against doxorubicin cardiotoxicity via improving mitochondrial function in mouse hearts

  2017cites this paper
• BMP 7 mediates the anticancer effect of honokiol by upregulating p 53 in HCT 116 cells

  2017cites this paper
• BMP7 mediates the anticancer effect of honokiol by upregulating p53 in HCT116 cells.

  2017cites this paper
• Effect of weekly or daily dosing regimen of Gefitinib in mouse models of lung cancer

  2017cites this paper
• Irisin reverses the IL-6 induced epithelial-mesenchymal transition in osteosarcoma cell migration and invasion through the STAT3/Snail signaling pathway

  2017cites this paper